MODULATION OF HIV-1 REPLICATION BY CYTOKINES AND SOLUBLE CYTOKINE RECEPTORS

细胞因子和可溶性细胞因子受体对 HIV-1 复制的调节

基本信息

  • 批准号:
    2568961
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
  • 资助国家:
    美国
  • 起止时间:
  • 项目状态:
    未结题

项目摘要

Our previous studies have shown that the cytokine, tumor necrosis factor-a (TNF), stimulates HIV-1 replication in chronically infected T lymphocytic and monocytic cell lines and that a soluble, dimeric form of the 80 kD TNF receptor (TNFR:Fc) could effectively block this induction. The ratio of receptor to TNF was critical, with optimal inhibition requiring a 5-fold molar excess of TNFR:Fc. The cytokine, interleukin-4 (IL-4), has been reported to both enhance and inhibit replication of HIV-1 in human monocytes/macrophages (MO) in vitro, depending on the state of cellular differentiation. We tested purified soluble human IL-4 receptors (sIL-4R) for their ability to modulate the effects of IL-4 on HIV-infected MO. We find that IL-4, when present throughout infection, inhibits HIV-1 replication in differentiated macrophages. In contrast, IL-4 added at later times during infection enhanced HIV replication. In addition, sIL4R, when used at low ratios with respect to the IL-4 concentration, increased the IL-4-mediated inhibition of virus replication in differentiated macrophages. However, when sIL-4R were present 100-fold in excess of IL-4, the inhibitory effects of the cytokine were reversed. These results suggest that sIL-4R can function as an agonist to augment the biological effects of IL-4 when used at concentrations equivalent to IL-4, but at a high molar excess they function as an antagonist. The comparative effects of human and murine soluble IL-4 receptors, as well as anti-IL-4 antibodies are currently under investigation. These results will provide more insight into the complex nature of cytokine/cytokine receptor networks that may exist in vivo, and the potential complications that may result from therapeutic use of soluble cytokine receptors. TNF has been shown to stimulate HIV-1 replication in vitro via activation of the cellular transcription factor, NF-kB. Oxidative stress also induces HIV replication through activation of NF-kB, and this effect could be reduced by selenium supplementation. The trace element, selenium, is incorporated into proteins as the amino acid selenocysteine, is essential for a functional immune system, can inhibit the expression of some viruses, and has been suggested as a therapeutic supplement in HIV infection. Since TNF and oxidative stress induce HIV by the same mechanism, we evaluated the effect of Se on TNF-induced HIV. We find that TNF-mediated induction of HIV-1 expression in both chronically infected T lymphocytic and monocytic cells can be reduced by selenium supplementation. Although selenium failed to suppress acute HIV infection of primary human T lymphocytes and monocytes, it did reduce the enhancing effects of TNF on acute HIV infection of monocytes, but not T cells. Thus, selenium supplementation may have some benefit as a supportive therapy in HIV-infected patients but, alone, would be incapable of ablating the detrimental effects of TNF.
我们以前的研究表明,细胞因子,肿瘤坏死, 因子-a(TNF),刺激HIV-1在慢性感染T细胞中复制 淋巴细胞和单核细胞细胞系以及可溶性二聚体形式的 80 kD TNF受体(TNFR:Fc)可有效阻断这种诱导作用。 受体与TNF的比例是关键,具有最佳抑制作用 需要5倍摩尔过量的TNFR:Fc。细胞因子白细胞介素-4 据报道,IL-4可以增强和抑制 体外人单核细胞/巨噬细胞(MO)中的HIV-1,取决于 细胞分化的状态。 我们测试了纯化的可溶性人IL-4 受体(sIL-4 R)调节IL-4对 感染艾滋病的MO 我们发现IL-4,当在整个感染过程中存在时, 抑制HIV-1在分化的巨噬细胞中的复制。 与此相反, 在感染后期加入IL-4可增强HIV复制。 在 另外,当相对于IL-4以低比例使用时, 浓度,增加IL-4介导的病毒抑制 在分化的巨噬细胞中复制。 但是,当sIL-4 R 存在超过IL-4 100倍, 细胞因子逆转。 这些结果表明,sIL-4 R可以发挥作用, 作为一种激动剂,当用于 浓度相当于IL-4,但在高摩尔过量时, 作为一种拮抗剂。 人类和小鼠的比较效果 可溶性IL-4受体以及抗IL-4抗体目前 在研究中 这些结果将提供更多的洞察力, 细胞因子/细胞因子受体网络的复杂性质可能存在于 体内,以及治疗可能导致的潜在并发症 使用可溶性细胞因子受体。 TNF已被证明刺激HIV-1 通过激活细胞转录因子进行体外复制, NF-κ B 氧化应激也通过激活诱导HIV复制 NF-kB的这种作用可通过补硒来降低。 微量元素硒以氨基酸的形式结合到蛋白质中。 酸性硒代半胱氨酸是功能性免疫系统所必需的, 抑制某些病毒的表达,并被认为是一种 艾滋病毒感染的治疗补充剂。 由于TNF和氧化应激 通过相同的机制诱导HIV,我们评估了Se对 TNF诱导的HIV。 我们发现TNF介导的HIV-1表达诱导 在慢性感染的T淋巴细胞和单核细胞中, 减少硒的补充。 虽然硒未能 抑制原代人T淋巴细胞急性HIV感染, 单核细胞,它确实降低了TNF对急性HIV的增强作用, 单核细胞感染,而不是T细胞。 因此,补充硒 作为HIV感染者的支持性治疗, 但是,单独的,将无法消除的有害影响, 的tnf

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

K. A CLOUSE-STREBEL其他文献

K. A CLOUSE-STREBEL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('K. A CLOUSE-STREBEL', 18)}}的其他基金

REGULATION OF M-CSF AND ET-1 PRODUCTION IN HUMAN MONOCYTES
人单核细胞中 M-CSF 和 ET-1 产生的调节
  • 批准号:
    6101219
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
REGULATION OF CYTOKINE EXPRESSION BY HIV
HIV 对细胞因子表达的调节
  • 批准号:
    2568960
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
MODULATION OF HIV-1 REPLICATION BY CYTOKINES AND SOLUBLE CYTOKINE RECEPTORS
细胞因子和可溶性细胞因子受体对 HIV-1 复制的调节
  • 批准号:
    6161280
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
REGULATION OF CYTOKINE EXPRESSION BY HIV
HIV 对细胞因子表达的调节
  • 批准号:
    6101217
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Cytokine Networks and HIV Pathogenesis
细胞因子网络和 HIV 发病机制
  • 批准号:
    6839792
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
REGULATION OF CYTOKINE EXPRESSION BY HIV
HIV 对细胞因子表达的调节
  • 批准号:
    6436378
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Modulation of HIV Replication by Cytokines, Cytokine Ant
细胞因子、细胞因子 Ant 对 HIV 复制的调节
  • 批准号:
    6682424
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Identifying biological agents that counteract the effect
识别抵消影响的生物制剂
  • 批准号:
    6679844
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Modulation of HIV-1 Replication by Cytokines
细胞因子对 HIV-1 复制的调节
  • 批准号:
    6545874
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Regulation of Cytokine Expression by HIV:Potential point
HIV对细胞因子表达的调节:潜在点
  • 批准号:
    6679835
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似海外基金

How do cytokine receptors transmit signals?
细胞因子受体如何传递信号?
  • 批准号:
    DP230102422
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Discovery Projects
Protein Translation Control of Cytokine Receptors
细胞因子受体的蛋白质翻译控制
  • 批准号:
    RGPIN-2018-04852
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Discovery Grants Program - Individual
Deciphering novel cross-talk between innate cytokine receptors
破译先天细胞因子受体之间的新型串扰
  • 批准号:
    DP210103122
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
    Discovery Projects
Protein Translation Control of Cytokine Receptors
细胞因子受体的蛋白质翻译控制
  • 批准号:
    RGPIN-2018-04852
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
    Discovery Grants Program - Individual
Protein Translation Control of Cytokine Receptors
细胞因子受体的蛋白质翻译控制
  • 批准号:
    RGPIN-2018-04852
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
    Discovery Grants Program - Individual
Protein Translation Control of Cytokine Receptors
细胞因子受体的蛋白质翻译控制
  • 批准号:
    RGPIN-2018-04852
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
    Discovery Grants Program - Individual
A dissection of transmembrane signal transduction and downstream signaling response in cytokine receptors
细胞因子受体跨膜信号转导和下游信号反应的剖析
  • 批准号:
    412345
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
    Fellowship Programs
Protein Translation Control of Cytokine Receptors
细胞因子受体的蛋白质翻译控制
  • 批准号:
    RGPIN-2018-04852
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
    Discovery Grants Program - Individual
Development of analysis method of inflammation-related proteins in serum using inflammatory cytokine receptors
开发利用炎症细胞因子受体分析血清中炎症相关蛋白的方法
  • 批准号:
    17K18360
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Mutations and single nucleotide polymorphisms of cytokine receptors in Kawasaki disease
川崎病细胞因子受体突变及单核苷酸多态性
  • 批准号:
    16K10020
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了